Skip to content

Clinical trials

Phase 1 Neoplasm Metastasis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1 Country / region: Italy Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20101
20111
20121
20133
20151
20164
20172
20181
20192
20203
20213
20224
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting8
Terminated7
Recruiting4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Eli Lilly and Company4
Incyte Corporation2
Pfizer2
AbbVie1
Bayer1
BeiGene1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis33
Carcinoma, Non-Small-Cell Lung10
Colorectal Neoplasms9
Neoplasms7
Breast Neoplasms4
Melanoma4
Stomach Neoplasms4
Carcinoma, Hepatocellular3
Endometrial Neoplasms3
Esophageal Neoplasms3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.